Skip to main content

Table 2 Pretransplant characteristics at the time of VAD implantation according to pre-transplant VAD infection

From: Ventricular assist devices as bridge to heart transplantation: impact on post-transplant infections

Characteristics

VAD infection n = 18

No VAD infection n = 17

Age, years; mean (SD)

52.3 (9.7)

39.1 (20)

Gender, male; n (%)

15 (83.3)

14 (82.4)

BMI, kg/m2; mean (SD)

28.4 (6.1)

22.9 (6)

Median time from VAD implantation to transplantation, days; median (IQR)

293.5 (121–593)

101 (37.5-206)

INTERMACS score; median (IQR)

1.5 (1–4)

2 (1–3)

Creatinine, μmol/l; mean (SD)

105.3 (58.6)

90.9 (35.6)

Type of VAD; n (%)

  

 - Heartmate® II

 - Berlin Heart® EXCOR

 - Heartware®

 - Thoratec®

 - Levitronics®

9 (37.1)

6 (34.3)

1 (14.3)

2 (11.4)

0 (0.0)

5 (29.4)

6 (35.3)

4 (23.5)

1 (5.8)

1 (5.8)

Active infection at the time of transplant

10/18 (55.5)

-

  1. VAD ventricular-assist device, BMI body mass index, INTERMACS interagency registry for mechanically assisted circulatory support